In view of the importance of BRCA1 in cancer development and treatment, and the conflicting data in the literature as cited above, we were prompted to carefully evaluate BRCA1 stability and localization in the cellular response to diverse-acting DNA damaging agents. The gene discussed is BRCA1; the disease is cancer.